Premium
Low‐molecular‐weight heparin added to aspirin in the prevention of recurrent early‐onset pre‐eclampsia in women with inheritable thrombophilia: the FRUIT‐RCT: a rebuttal
Author(s) -
BUJOLD E.,
GOUIN K.,
CÔTÉ S.
Publication year - 2012
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2012.04688.x
Subject(s) - aspirin , medicine , thrombophilia , low molecular weight heparin , randomized controlled trial , rebuttal , heparin , preeclampsia , gynecology , pregnancy , biology , thrombosis , genetics , political science , law
See also de Vries JIP, Hague WM and van Pampus MG; for the FRUIT‐Investigators. Low‐molecular‐weight heparin added to aspirin in the prevention of recurrent early‐onset pre‐eclampsia in women with inheritable thrombophilia: the FRUIT‐RCT: a reply to a rebuttal. This issue, pp 1196; de Vries JIP, van Pampus MG, Hague WM, Bezemer PD, Joosten JH, on behalf of FRUIT Investigators. Low‐molecular‐weight heparin added to aspirin in the prevention of recurrent early‐onset preeclampsia in women with inheritable thrombophilia: the FRUIT‐RCT. J Thromb Haemost 2012; 10 : 64–72.